Investors Sue Ligand Pharmaceuticals (NASDAQ: LGND) for $3.8 Billion

Just fourteen days after Rev. Fr. Emmanuel published an open letter to Congress alleging a multi-year accounting and securities fraud at Ligand Pharmaceuticals...